Advertisement

Fungal Infections in the Pediatric Age Group

  • Luluah Al-Mubarak
  • Colleen Cotton
  • Sheila Fallon FriedlanderEmail author
Chapter
  • 945 Downloads

Abstract

Cutaneous fungal infections occur in the pediatric age group and are a particular concern when they occur in premature or otherwise immunocompromised children. Clinical manifestations can result from infection with yeasts as well as dermatophytes. The most common fungal infection in healthy infants is Candida diaper dermatitis, which usually occurs as a secondary phenomenon following the development of contact dermatitis from the irritating effects of stool and urine. Candida paronychia from thumb-sucking may also occur in this age group. Older children are more likely to contract dermatophyte infections, sometimes transmitted from pets (e.g., Microsporum canis scalp or skin infections) or from other infected individuals (Trichophyton tonsurans). Adolescents are at higher risk for pityrosporum infections (commonly labeled with the misnomer tinea versicolor) and dermatophyte infections of the groin, feet, and nails. Systemic infection from any of the aforementioned infections does not occur in healthy, immunocompetent infants and children. Premature and immunocompromised individuals however are at risk for invasive infection with common pathogens such as Candida, pityrosporum, and opportunistic fungal pathogens such as Aspergillus. The increased incidence of immunosuppressed children, the use of immunosuppressive agents, and broad-spectrum anti-infective drugs make life-threatening infections from ubiquitous fungi a more common occurrence in children. A high index of suspicion for these disorders in at-risk populations, and early recognition of suspicious lesions is crucial to decrease associated morbidity and mortality. In this chapter, we will present several representative cases of fungal infections with potential for significant consequences in the pediatric population.

Keywords

Fungal infection Pediatrics Candida Aspergillus Tinea Opportunistic fungal infection Mucormycosis 

Notes

Conflict of Interest

Dr. Friedlander has conducted research on topical antifungal lacquers for Valeant Pharmaceuticals and served as a consultant for Sandoz Pharmaceuticals.

References

  1. 1.
    Smolinski KN, Shah SS, Honig PJ, Yan AC. Neonatal cutaneous fungal infections. Curr Opin Pediatr. 2005;17(4):486–93.CrossRefPubMedGoogle Scholar
  2. 2.
    Hook KP, Eichenfield LF. Approach to the neonate with ecchymoses and crusts. Dermatol Ther. 2011;24(2):240–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Levy I, Rubin LG, Vasishtha S, et al. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis. 1998;26:1086–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Rowen JL. Mucocutaneous candidiasis. Semin Perinatol. 2003;27:406–13.CrossRefPubMedGoogle Scholar
  5. 5.
    Diana A, Epiney M, Ecoffey M, Pfister RE. ‘White dots on the placenta and red dots on the baby’: congenital cutaneous candidiasis—a rare disease of the neonate. Acta Paediatr. 2004;93:996–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Passeron T, Desruelles F, Gari-Toussaint M, et al. Invasive fungal dermatitis in a 770 gram neonate. Pediatr Dermatol. 2004;21:260–1.CrossRefPubMedGoogle Scholar
  7. 7.
    Roilides E, Zaoutis TE, Walsh TJ. Invasive zygomycosis in neonates and children. Clin Microbiol Infect. 2009;15 Suppl 5:50–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Kanaan IC, Santos TB, Kac BK, Souza AM, Cerqueira AM. Majocchi’s granuloma—case report. An Bras Dermatol. 2015;90(2):251–3.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Bressan AL, Silva RS, Fonseca JC, de Alves MF. Majocchi’s granuloma. An Bras Dermatol. 2011;86:797–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Molina-Leyva A, Perez-Parra S, Garcia-Garcia F. Case for diagnosis. An Bras Dermatol. 2014;89(5):839–40.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Chen HH, Chiu HC. Facial Majocchi’s granuloma caused by Trichophyton tonsurans in an immunocompetent patient. Acta Derm Venereol. 2003;83:65–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Kim JE, Won CH, Chang S, Lee MW, Choi JH, Moon KC. Majocchi’s granuloma mimicking Kaposi sarcoma in a heart transplant patient. J Dermatol. 2011;38:927–9.PubMedGoogle Scholar
  13. 13.
    Mays SR, Bogle MA, Bodey GP. Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol. 2006;7(1):31–43.CrossRefPubMedGoogle Scholar
  14. 14.
    Grossman ME. Cutaneous manifestations of infection in the immunocompromised host. Baltimore: Williams & Wilkins; 1995. p. 188.Google Scholar
  15. 15.
    Brown AE. Overview of fungal infections in cancer patients. Semin Oncol. 1990;17(3 Suppl 6):2–5.Google Scholar
  16. 16.
    Dekio F, Bhatti TR, Zhang SX, Sullivan KV. Positive impact of fungal histopathology on immunocompromised pediatric patients with histology-proven invasive fungal infection. Am J Clin Pathol. 2015;144(1):61–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Sirignano S, Blake P, Turrentine JE, Dominguez AR. Primary cutaneous zygomycosis secondary to minor trauma in an immunocompromised pediatric patient: a case report. Dermatol Online J. 2014;15:20(6).Google Scholar
  18. 18.
    Roden MM, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.CrossRefPubMedGoogle Scholar
  19. 19.
    Groll AH, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014;15(8):e327–40.CrossRefPubMedGoogle Scholar
  20. 20.
    Bodey GP, et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002;47(5):659–66.CrossRefPubMedGoogle Scholar
  21. 21.
    Howells RC, Ramadan HH. Usefulness of computed tomography and magnetic resonance in fulminant invasive fungal rhinosinusitis. Am J Rhinol. 2001;15(4):255–61.PubMedGoogle Scholar
  22. 22.
    Oz Y, Kiraz N. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods. Expert Rev Anti Infect Ther. 2011;9(3):289–98.CrossRefPubMedGoogle Scholar
  23. 23.
    Tragiannidis A, Dokos C, Lehrnbecher T, Groll AH. Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice. Drugs. 2012;72(5):685–704.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Luluah Al-Mubarak
    • 1
  • Colleen Cotton
    • 2
  • Sheila Fallon Friedlander
    • 3
    Email author
  1. 1.Department of DermatologyPrince Sultan Military Medical CityRiyadhSaudi Arabia
  2. 2.Division of Dermatology, Department of MedicineUniversity of ArizonaTucsonUSA
  3. 3.Department of Dermatology and PediatricsUniversity of California San Diego School of Medicine/Rady Children’s HospitalSan DiegoUSA

Personalised recommendations